Michelle L. Turski

2.1k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Michelle L. Turski is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Nutrition and Dietetics. According to data from OpenAlex, Michelle L. Turski has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Nutrition and Dietetics. Recurrent topics in Michelle L. Turski's work include Melanoma and MAPK Pathways (7 papers), Cancer Mechanisms and Therapy (5 papers) and Trace Elements in Health (5 papers). Michelle L. Turski is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Cancer Mechanisms and Therapy (5 papers) and Trace Elements in Health (5 papers). Michelle L. Turski collaborates with scholars based in United States, United Kingdom and Switzerland. Michelle L. Turski's co-authors include Dennis J. Thiele, Donita C. Brady, Christopher M. Counter, Yasuhiro Nose, Daniel W. Neef, Matthew S. Crowe, A. Chaikuad, Stefan Knapp, G. Aaron Hobbs and Sharon L. Campbell and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Michelle L. Turski

18 papers receiving 1.6k citations

Hit Papers

Copper is required for oncogenic BRAF signalling and tumo... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle L. Turski United States 11 690 645 399 270 153 20 1.6k
Pei Feng United States 19 780 1.1× 521 0.8× 330 0.8× 372 1.4× 111 0.7× 31 1.7k
Michael A. Cater Australia 21 1.2k 1.7× 709 1.1× 892 2.2× 530 2.0× 362 2.4× 28 2.5k
Oleg Y. Dmitriev United States 25 980 1.4× 1.3k 2.0× 524 1.3× 453 1.7× 45 0.3× 50 2.3k
Donita C. Brady United States 25 948 1.4× 1.3k 2.0× 723 1.8× 242 0.9× 478 3.1× 39 2.7k
Angelica M. Merlot Australia 21 378 0.5× 1.0k 1.6× 631 1.6× 73 0.3× 249 1.6× 24 2.2k
Byung‐Eun Kim United States 14 1.8k 2.6× 712 1.1× 523 1.3× 941 3.5× 165 1.1× 15 2.6k
Tracey Rae United States 10 1.2k 1.8× 667 1.0× 298 0.7× 405 1.5× 34 0.2× 13 1.9k
Michael Huang Australia 26 553 0.8× 1.5k 2.4× 418 1.0× 81 0.3× 227 1.5× 49 2.7k
Kuniyuki Katano Japan 16 587 0.9× 652 1.0× 1.1k 2.7× 60 0.2× 177 1.2× 32 1.8k
Or Kakhlon Israel 21 560 0.8× 724 1.1× 115 0.3× 91 0.3× 166 1.1× 41 1.9k

Countries citing papers authored by Michelle L. Turski

Since Specialization
Citations

This map shows the geographic impact of Michelle L. Turski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle L. Turski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle L. Turski more than expected).

Fields of papers citing papers by Michelle L. Turski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle L. Turski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle L. Turski. The network helps show where Michelle L. Turski may publish in the future.

Co-authorship network of co-authors of Michelle L. Turski

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle L. Turski. A scholar is included among the top collaborators of Michelle L. Turski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle L. Turski. Michelle L. Turski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández, Karen S., Michelle L. Turski, Avanthi Tayi Shah, et al.. (2019). Ewing sarcoma in a child with neurofibromatosis type 1. Molecular Case Studies. 5(5). a004580–a004580. 1 indexed citations
2.
Turski, Michelle L., Smruti J. Vidwans, Filip Jankú, et al.. (2016). Genomically Driven Tumors and Actionability across Histologies:BRAF-Mutant Cancers as a Paradigm. Molecular Cancer Therapeutics. 15(4). 533–547. 62 indexed citations
3.
Agarwal, Rishi, Michelle L. Turski, Smruti J. Vidwans, et al.. (2015). Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies.. PubMed. 19(103). 101–8.
4.
Agarwal, Rishi, Michelle L. Turski, Smruti J. Vidwans, et al.. (2015). Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome.. PubMed. 19(103). 109–16. 9 indexed citations
5.
Brady, Donita C., Michelle L. Turski, A. Chaikuad, et al.. (2014). Copper is required for oncogenic BRAF signaling and tumorigenesis. Molecular Cancer Research. 12. 1 indexed citations
6.
Brady, Donita C., Matthew S. Crowe, Michelle L. Turski, et al.. (2014). Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature. 509(7501). 492–496. 487 indexed citations breakdown →
7.
Vidwans, Smruti J., Michelle L. Turski, Filip Jankú, et al.. (2014). A framework for genomic biomarker actionability and its use in clinical decision making. Oncoscience. 1(10). 614–623. 29 indexed citations
8.
Agarwal, Rishi, Michelle L. Turski, Smruti J. Vidwans, et al.. (2014). Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome.. PubMed. 18(101). 323–30. 4 indexed citations
9.
Brady, Donita C., Michelle L. Turski, A. Chaikuad, et al.. (2014). Abstract IA09: Copper is required for oncogenic BRAF signaling and tumorigenesis. Molecular Cancer Research. 12(12_Supplement). IA09–IA09. 1 indexed citations
10.
Brady, Donita C., Matthew S. Crowe, Michelle L. Turski, et al.. (2014). Abstract 4427: Copper is required for oncogenic BRAF signaling and tumorigenesis. Cancer Research. 74(19_Supplement). 4427–4427. 2 indexed citations
11.
Brady, Donita C., Matthew S. Crowe, Michelle L. Turski, Dennis J. Thiele, & Christopher M. Counter. (2013). Abstract 4294: Copper is required for oncogenic BRAF signaling and tumorigenesis.. Cancer Research. 73(8_Supplement). 4294–4294. 1 indexed citations
12.
Turski, Michelle L., Donita C. Brady, Hyung J. Kim, et al.. (2012). A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling. Molecular and Cellular Biology. 32(7). 1284–1295. 250 indexed citations
13.
Kim, Byung‐Eun, et al.. (2010). Cardiac Copper Deficiency Activates a Systemic Signaling Mechanism that Communicates with the Copper Acquisition and Storage Organs. Cell Metabolism. 11(5). 353–363. 137 indexed citations
14.
Neef, Daniel W., Michelle L. Turski, & Dennis J. Thiele. (2010). Modulation of Heat Shock Transcription Factor 1 as a Therapeutic Target for Small Molecule Intervention in Neurodegenerative Disease. PLoS Biology. 8(1). e1000291–e1000291. 150 indexed citations
15.
Fetchko, Michael J., Lilit Atanesyan, Kurt Steiner, et al.. (2010). The Drosophila Copper Transporter Ctr1C Functions in Male Fertility. Journal of Biological Chemistry. 285(22). 17089–17097. 29 indexed citations
16.
Turski, Michelle L. & Dennis J. Thiele. (2008). New Roles for Copper Metabolism in Cell Proliferation, Signaling, and Disease. Journal of Biological Chemistry. 284(2). 717–721. 333 indexed citations
17.
Turski, Michelle L. & Dennis J. Thiele. (2007). Drosophila Ctr1A Functions as a Copper Transporter Essential for Development. Journal of Biological Chemistry. 282(33). 24017–24026. 55 indexed citations
18.
McGovern, Vicki L., et al.. (2003). A targeted gain of function screen in the embryonic CNS of Drosophila. Mechanisms of Development. 120(10). 1193–1207. 20 indexed citations
20.
Biczysko, W, et al.. (1987). Morphological changes in femoropopliteal venous grafts.. PubMed. 86(6). 340–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026